Body fluid analysis has very unique and complicated challenges. Samples can come into the lab from a wide variety of sources and the analytical process is often not standardized to the sample source and matrix.  To further complicate the...

Biomarkers of Heart Failure: Current Status and Future Promise is the second of 12 programs in AACC’s “High-Value Tests for High-Impact Diseases” webinar series. During this program, AACC President-Elect, Robert Christenson, PhD,...

The Role of Biomarkers of Inflammation in Cardiovascular Disease is the third of 12 programs in AACC’s “High-Value Tests for High-Impact Diseases” webinar series. The webinar features Paul Ridker, MD, who will examine the uses...

Delta checks play a pivotal role in the quality improvement process by comparing current laboratory results to previous results. If there is a discrepancy between the results it could be due to either sample error, analytical error or a...

The Pros and Cons of Using HbA1c for Diabetes Diagnosis is the fourth of 12 programs in AACC’s “High-Value Tests for High-Impact Diseases” webinar series. The new criteria for diagnosing diabetes added HbA1c to the list of tests...

The Oak Ridge Conference is the American Association for Clinical Chemistry’s annual forum for emerging clinical diagnostic technologies. The conference focuses exclusively on pre-commercial technologies, and session topics are updated...

Molecular-based laboratory tests are continuing to gain prominence in the clinical laboratory setting. Therefore, today’s laboratory professionals must be able to understand, interpret, and advise clinicians on molecular test...

Glucose Meter Accuracy and Glycemic Control: How Good is Good Enough? is the fifth of 12 programs in AACC’s “High-Value Tests for High-Impact Diseases” webinar series. Most glucose meters were initially designed for home use to...

New Recommendations for Diagnosis of Hyperglycemia in Pregnancy is the sixth of 12 programs in AACC’s “High-Value Tests for High-Impact Diseases” webinar series. The diagnostic criteria for gestational diabetes mellitus (GDM) has...

Biomarkers for Chronic Kidney Disease: Glomerular Filtration and Progression of Kidney Disease is the seventh of 12 programs in AACC’s “High-Value Tests for High-Impact Diseases” webinar series. According to the NIDDK, more than...

Biomarkers for Chronic Kidney Disease: Urine Albumin and Multi-markers is the eighth of 12 programs in AACC’s “High-Value Tests for High-Impact Diseases” webinar series. Today, urine albumin is a widely accepted biomarker of...

Mass spectrometry has played a pivotal role in a variety of scientific disciplines. Today it is becoming an integral part of the clinical laboratory. Lab professionals often describe “mass spec” as a complimentary method to immunoassay,...

Biomarkers for Acute Kidney Injury: Now and the Future is the ninth of 12 programs in AACC’s “High-Value Tests for High-Impact Diseases” webinar series. New markers for identifying early stress response of the kidneys to sudden...

Each year CCJ produces a dedicated special issue. The 2012 special issue is on cardiovascular disease (CVD). This conference has been designed to compliment this special issue and further enhance the global understanding of...

This 24th International CPOCT symposium will look at the development of point-of-care testing in different settings and will consider the testing benefits provided by POCT alongside the impact of quality errors on patient care....

Perspectives in Thyroid Testing: Pros and Cons of Immunoassay and Mass Spectrometry is the tenth of 12 programs in AACC’s “High-Value Tests for High-Impact Diseases” webinar series. For over 50 years immunoassay has been the...

Effective Laboratory Testing for Thyroid Health during Pregnancy is the eleventh of 12 programs in AACC’s “High-Value Tests for High-Impact Diseases” webinar series.  Good thyroid health during pregnancy is an important factor...

Role of Clinical Lab Testing in Diagnosis and Management of Thyroid Cancer is the final program in AACC’s “High-Value Tests for High-Impact Diseases” webinar series. Thyroid cancer is fairly uncommon--about 37,000 people are...